Stock listing
Nirvana Life Sciences Inc
Selected listing: NIRV.X · CSE · CAD · CA
Nirvana Life Sciences Inc Class X Shares (CSE:NIRV.X), Health Technology. Latest release Jan 29, 2024: Nirvana Life Sciences Inc. Announces Receipt of First…
- Ticker
- CSE:NIRV.X
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- CSE
- Currency
- CAD
About Nirvana Life Sciences Inc
Nirvana Life Sciences Inc (Ticker: NIRV.X) is a public company based in Canada, focusing on the life sciences sector. Investors can find more information about its operations and developments on its corporate page.
Latest news from Nirvana Life Sciences Inc
Nirvana Life Sciences Inc. Announces Receipt of First North American Production of SOSA, a Patented, WHO Approved, Herbal Treatment for Opiate Addiction
January 29, 2024
Nirvana Life Sciences Inc. announces agreement to acquire the licensed distributor of a Patented, WHO approved, herbal treatment for opiate addiction
November 21, 2022
Nirvana Life Sciences Inc. Deuterates 7-Hydroxymitragynine to Create D7-h, an Analogue that May Improve Research and Formulations using Kratom Derivatives
September 22, 2022
Nirvana Life Sciences Inc. Announces a Method for Producing MDMA that Reduces Manufacturing Time by Two Thirds
September 7, 2022
Nirvana Life Sciences Inc. Announces License for a Delivery System for Psychedelic APIs
July 6, 2022
Research Nirvana Life Sciences Inc
Nirvana Life Sciences Inc company profile
View the public company page for Nirvana Life Sciences Inc on 6ix.
Nirvana Life Sciences Inc news
Read company news and market updates connected to Nirvana Life Sciences Inc.
Nirvana Life Sciences Inc investor events
Find investor webinars, events, and replay context for Nirvana Life Sciences Inc.